Division of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, NY 10065, USA.
J Mol Med (Berl). 2011 Aug;89(8):753-69. doi: 10.1007/s00109-011-0764-0. Epub 2011 May 10.
Lymph node metastasis is a strong predictor of poor outcome in cancer patients. Animal studies of lymph node metastasis are constrained by difficulties in the establishment of appropriate animal models, limitations in the noninvasive monitoring of lymph node metastasis progression, and challenges in the pathologic confirmation of lymph node metastases. In this comprehensive review, we summarize available preclinical animal cancer models for noninvasive imaging and identification of lymph node metastases of non-hematogenous cancers. Furthermore, we discuss the strengths and weaknesses of common noninvasive imaging modalities used to identify tumor-bearing lymph nodes and provide guidelines for their pathological confirmation.
淋巴结转移是癌症患者预后不良的强有力预测指标。淋巴结转移的动物研究受到建立合适的动物模型的困难、对淋巴结转移进展的非侵入性监测的限制以及对淋巴结转移的病理确认的挑战的限制。在这篇全面的综述中,我们总结了目前用于非侵入性成像和识别非血源性癌症淋巴结转移的临床前动物癌症模型。此外,我们还讨论了用于识别肿瘤性淋巴结的常用非侵入性成像方式的优缺点,并为其病理确认提供了指导方针。
J Mol Med (Berl). 2011-5-10
Clin Imaging. 2023-11
Biomed Pharmacother. 2011-6-12
Int J Mol Sci. 2013-7-3
Mol Ther Oncolytics. 2021-6-12
Cancer Biol Ther. 2020-6-2
Mol Med Rep. 2013-10-10
Expert Opin Drug Deliv. 2009-10